Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island
NCT ID: NCT04932681
Last Updated: 2022-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
520 participants
OBSERVATIONAL
2022-04-30
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To knowledge of investigators, no study has been carried out in Reunion Island on the use of plants and other alternative and complementary medicines among cancer patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Needs Assessment of Cancer Patients With Complementary and Alternative Medicines
NCT03954509
The Use of Cannabidiol in Cancer Patients
NCT05407298
Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
NCT00949390
Shared Decision Making on Care Pathways and CAMs: A Pilot Study
NCT05388734
The Use of Alternative Medicine by Palliative Care Patients
NCT03260946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Qualitative group
Interview about the use of Complementary and Alternative Medecine
No interventions assigned to this group
Quantitative group
Questionnaire about the use of Complementary and Alternative Medecine
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from cancer (solid tumors, hematological malignancies)
* Able to answer a questionnaire
* Patient who does not oppose to the research
Exclusion Criteria
* Persons who do not understand French or Reunionese Creole
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
APLAMEDOM
UNKNOWN
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU La Réunion
Saint-Denis, , Reunion
Clinique Saint Clotilde
Sainte-Clotilde, , Reunion
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/CHU/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.